Spared Motivational Modulation of Cognitive Effort in a Maternal Immune Activation Model of Schizophrenia Risk

被引:14
|
作者
Bates, Vanessa [1 ]
Maharjan, Ashim [1 ]
Millar, Jessica [1 ]
Bilkey, David K. [1 ]
Ward, Ryan D. [1 ]
机构
[1] Univ Otago, Dept Psychol, POB 56, Dunedin 9054, New Zealand
关键词
maternal immune activation; signaled reward probability; motivation; schizophrenia; poly I:C; NEURODEVELOPMENTAL ANIMAL-MODEL; NEGATIVE SYMPTOMS; DOPAMINERGIC HYPERFUNCTION; REWARD PROBABILITY; RAT MODEL; DEFICITS; INHIBITION; ETIOLOGY; IMPACT; MICE;
D O I
10.1037/bne0000230
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Maternal immune activation (MIA) during gestation is a significant risk factor for development of schizophrenia and other neurodevelopmental diseases. In animal models of this risk factor, MIA during pregnancy can produce offspring that recapitulate certain aspects of the behavioral and neurophysiological impairments seen in schizophrenia. Here, the authors tested the effect of polyinosinic-polycytidylic acid (poly I:C)-induced MIA in a task that explicitly assays the interaction between motivation and cognition. In our paradigm, discrimination accuracy during a sustained-attention task is differentially impacted by environmental cues that signal the probability of reward for accurate performance. Cognition-motivation interactions are implicated in producing functional impairments in patients. Therefore, to the extent that this MIA model recapitulates such impairments, the authors predicted impaired ability of reward-associated signals to modulate cognitive performance in MIA rat offpsring. Adult offspring of dams in which MIA was induced displayed impaired prepulse inhibition relative to controls, verifying a functional effect of poly I: C induction. Despite this deficit, there were no differences between MIA and control rats in any aspects of task learning or performance, including under extinction and reacquisition conditions. These results indicate that MIA spares functioning of some of the cognitive, motivational, and decision-making processes that are impacted in schizophrenia and suggest that MIA as an isolated manipulation does not model the full range and nuance of the cognitive and motivational impairments in the disease. The authors suggest that some aspects of the functional impairment in schizophrenia and other neurodevelopmental diseases may be better modeled using multiple "hit" models of disease risk.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 50 条
  • [41] Placental Programming in a Rodent Model of Maternal Immune Activation
    Estevez, Karen Nunez
    Rondon-Ortiz, Alejandro
    Nguyen, Jenny
    Puraccio, Madeline
    Roderick, Ryland
    Kentner, Amanda
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 284 - 285
  • [42] SUSCEPTIBILITY AND RESILIENCE IN A MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION
    Mueller, Flavia
    Scarborough, Joseph
    Richetto, Juliet
    Schalbetter, Sina
    Weber-Stadlbauer, Ulrike
    Meyer, Urs
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S204 - S205
  • [43] Evaluation of the Behavioural and Neurobiological Consequences of Maternal Immune Activation in Male and Female Rat Offspring: A Developmental Model for Schizophrenia
    Neill, Jo
    Fasolino, Victoria
    Oladipo, Joanna
    Grayson, Ben
    Cadinu, Daniela
    Manca, Maurizio
    Podda, Giovanni
    Harte, Michael
    Idris, Nagi
    Murray, Katie
    Edye, Michelle
    Prinssen, Eric
    Knuesel, Irene
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S594 - S595
  • [44] Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia
    Chou, Shinnyi
    Jones, Sean
    Li, Ming
    BRAIN RESEARCH, 2015, 1618 : 122 - 135
  • [45] Exploring Risk and Resilience Following 11ßHydroxylase Antagonism in a Rodent Model of Maternal Immune Activation
    Martz, Julia
    Shelton, Micah A.
    Geist, Laurel
    Seney, Marianne L.
    Kentner, Amanda
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 149 - 149
  • [46] Modelling white matter neuron pathology in schizophrenia using maternal immune activation
    Duchatel, R.
    Jobling, P.
    Graham, B.
    Harms, L.
    Michie, P.
    Hodgson, D.
    Tooney, P.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 315 - 315
  • [47] Resveratrol ameliorates the effect of maternal immune activation associated with schizophrenia in adulthood offspring
    Ferreira, Frederico Rogerio
    Barros de Moura, Nathalia Souza
    Hassib, Lucas
    Pombo, Thatiane Rebelo
    NEUROSCIENCE LETTERS, 2020, 734
  • [48] Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats
    Taskiran, Mehmet
    Taskiran, Sacide Yildiz
    Unal, Gokhan
    Bozkurt, Nuh Mehmet
    Golgeli, Asuman
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024,
  • [49] Alternated Neurodevelopment and Immune Function a Nonhuman Primate Model of Maternal Immune Activation
    Bauman, Melissa
    Iosif, Ana-Maria
    Carter, Cameron
    McAllister, A. Kimberley
    Van de Water, Judy
    Ryan, Amy
    Murai, Takeshi
    Phi, Casey
    Lesh, Tyler
    Vlasova, Roza
    Styner, Martin
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S251 - S251
  • [50] Enhanced Hippocampal Neuronal Excitability and LTP Persistence Associated With Reduced Behavioral Flexibility in the Maternal Immune Activation Model of Schizophrenia
    Savanthrapadian, Shakuntala
    Wolff, Amy R.
    Logan, Barbara J.
    Eckert, Michael J.
    Bilkey, David K.
    Abraham, Wickliffe C.
    HIPPOCAMPUS, 2013, 23 (12) : 1395 - 1409